From the announcement last week"Coviu and ResApp will work...

From the announcement last week

"Coviu and ResApp will work together under a joint development agreement for the next four
months to integrate ResAppDx-EU into Coviu’s browser-based telehealth platform, to devise a workflow for directing patients and clinicians towards the use of ResAppDx-EU in appropriate circumstances and to prepare a list of actions for clinicians to take after reviewing the test results"

Whilst the app may be easy to use, it cannot be underestimated how much effort needs to be put in to develop the clinical workflows and decisions (protocols) around the use of the app to support the diagnosis (the second and third points above, from the announcement)

Key to the implementation and use of ResAppDx in a clinical setting, whether that will be Tele-Health or in an ED triage, will be clinician buy in and adoption of the technology.

The learnings from the German Hospital Pilot Study will be critical to this for ResApp and I'd like to see them build a clinical change/implementation capability within the team - ideally someone with a clinical background, who has implemented technology in these environments before. Having the right person lead this, will pay big dividends to the adoption and usage of the app down the track.